Sugimoto, M.; Hira, D.; Murata, M.; Kawai, T.; Terada, T.
Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy. Antibiotics 2020, 9, 645.
https://doi.org/10.3390/antibiotics9100645
AMA Style
Sugimoto M, Hira D, Murata M, Kawai T, Terada T.
Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy. Antibiotics. 2020; 9(10):645.
https://doi.org/10.3390/antibiotics9100645
Chicago/Turabian Style
Sugimoto, Mitsushige, Daiki Hira, Masaki Murata, Takashi Kawai, and Tomohiro Terada.
2020. "Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy" Antibiotics 9, no. 10: 645.
https://doi.org/10.3390/antibiotics9100645
APA Style
Sugimoto, M., Hira, D., Murata, M., Kawai, T., & Terada, T.
(2020). Effect of Antibiotic Susceptibility and CYP3A4/5 and CYP2C19 Genotype on the Outcome of Vonoprazan-Containing Helicobacter pylori Eradication Therapy. Antibiotics, 9(10), 645.
https://doi.org/10.3390/antibiotics9100645